High- and Low-Dose Oral Delayed-Release Mesalamine in Children With Mild-to-Moderately Active Ulcerative Colitis

por Winter, Harland S., Krzeski, Piotr, Heyman, Melvin B., Ibarguen-Secchia, Eduardo, Iwanczak, Barbara, Kaczmarski, Maciej, Kierkus, Jaroslaw, Kolaček, Sanja, Osuntokun, Bankole, Quiros, J. Antonio, Shah, Manoj, Yacyshyn, Bruce, Dunnmon, Preston M.
Publicado 2014